Half-year report · Q2
4202.TEDINET S100UOID
Period2024-04-01 → 2024-09-30
Filed2024-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥289.7bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥558.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥271.0bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥31.6bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥26.6bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥30.7bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥68.4bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥30.7bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥41.8bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥40.1bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥32.1bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥55.8bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥29.8bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥32.6bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥29.9bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥827.8bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥839.2bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥808.6bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥435.5bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥463.8bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥392.3bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥375.4bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥355.8bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥64.8bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥73.2bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥64.4bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥68.4bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥92.9bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥93.5bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥50.7bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥76.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥49.2bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥29.4bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥55.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥26.8bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥24.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥52.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥28.1bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥116.18 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥197.56 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥104.13 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 45.5% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.8% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.1% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 65
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥9.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥2.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥7.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥344m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥13.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥13.8bn |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥124.6bn |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥124.5bn |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥96m |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥15.2bn |
| jpcrp040300-q2r_E00818-000Materialsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥95.1bn |
| jpcrp040300-q2r_E00818-000Materialsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥88.5bn |
| jpcrp040300-q2r_E00818-000Materialsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥6.6bn |
| jpcrp040300-q2r_E00818-000Materialsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥14.3bn |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥7.2bn |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥7.2bn |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥0 |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥189m |
| jpcrp040300-q2r_E00818-000Safetyreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥47.1bn |
| jpcrp040300-q2r_E00818-000Safetyreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥47.1bn |
| jpcrp040300-q2r_E00818-000Safetyreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E00818-000Smartreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥19.6bn |
| jpcrp040300-q2r_E00818-000Smartreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥19.6bn |
| jpcrp040300-q2r_E00818-000Smartreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥51m |
| jpcrp040300-q2r_E00818-000Smartreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥215m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥293.6bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥286.9bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥6.7bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥31.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥303.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥289.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥13.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥31.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥9.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥2.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥6.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥122m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥11.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥11.8bn |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥108.8bn |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥108.7bn |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥71m |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥6.1bn |
| jpcrp040300-q2r_E00818-000Materialsreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥90.9bn |
| jpcrp040300-q2r_E00818-000Materialsreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥89.0bn |
| jpcrp040300-q2r_E00818-000Materialsreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E00818-000Materialsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥19.9bn |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥6.9bn |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥6.9bn |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥481m |
| jpcrp040300-q2r_E00818-000Safetyreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥47.1bn |
| jpcrp040300-q2r_E00818-000Safetyreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥47.1bn |
| jpcrp040300-q2r_E00818-000Safetyreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥140m |
| jpcrp040300-q2r_E00818-000Smartreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥19.7bn |
| jpcrp040300-q2r_E00818-000Smartreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥16.8bn |
| jpcrp040300-q2r_E00818-000Smartreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥2.9bn |
| jpcrp040300-q2r_E00818-000Smartreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥133m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥273.4bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥268.5bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥4.8bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥26.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥282.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥271.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥11.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥26.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 581
| Item | Context | Value | Unit |
|---|---|---|---|
| Proceeds from long term loans payable fin cf | CurrentYTDDuration | 22137000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -4107000000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -6888000000 | JPY |
| Redemption of bonds fin cf | Prior1YTDDuration | -10000000000 | JPY |
| Redemption of bonds fin cf | CurrentYTDDuration | -10000000000 | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | -0 | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -0 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -5713000000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -6894000000 | JPY |
| Dividends paid to non controlling interests fin cf | Prior1YTDDuration | -893000000 | JPY |
| Dividends paid to non controlling interests fin cf | CurrentYTDDuration | -765000000 | JPY |
| Repayments of lease obligations fin cf | Prior1YTDDuration | -642000000 | JPY |
| Repayments of lease obligations fin cf | CurrentYTDDuration | -725000000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -28102000000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -24043000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 5108000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | -1279000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | -574000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | -3968000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 93493000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 68408000000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 92919000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 64440000000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 92938000000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 93387000000 | JPY |
| Work in process | Prior1YearInstant | 24110000000 | JPY |
| Work in process | CurrentQuarterInstant | 25012000000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 65461000000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 65669000000 | JPY |
| Sales related expenses sga | Prior1YTDDuration | 9787000000 | JPY |
| Sales related expenses sga | CurrentYTDDuration | 11300000000 | JPY |
| Employees salaries and allowances sga | Prior1YTDDuration | 10808000000 | JPY |
| Employees salaries and allowances sga | CurrentYTDDuration | 11737000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 272000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 85000000 | JPY |
| Technical research expenses sga | Prior1YTDDuration | 11562000000 | JPY |
| Technical research expenses sga | CurrentYTDDuration | 12776000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00818-000MedicalHealthcareReportableSegmentMember | 6877000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00818-000SmartReportableSegmentMember | 16775000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00818-000SafetyReportableSegmentMember | 47132000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00818-000MaterialsReportableSegmentMember | 89032000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00818-000EngineeringPlasticsReportableSegmentMember | 108696000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 268514000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 2490000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 271004000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 271004000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00818-000MedicalHealthcareReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00818-000SmartReportableSegmentMember | 2884000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00818-000SafetyReportableSegmentMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |